Last updated on:
9/17/2014 |
Author: ProCon.org
David Hadorn, MD, PhD Biography
- Title:
- Senior Research Fellow and Director at the Centre for Assessment and Prioritisation in the Department of Public Health at the University of Otago Wellington School of Medicine
- Position:
- Pro to the question "Should Marijuana Be a Medical Option?"
- Reasoning:
-
“I have seen many patients with chronic pain, muscle spasms, nausea, anorexia, and other unpleasant symptoms obtain significant -- often remarkable -- relief from cannabis medicines, well beyond what had been provided by traditional (usually opiate-based) pain relievers.”
“Use of Cannabis Medicines in Clinical Practice,”
, July 17, 2003 - Theoretical Expertise Ranking:
-
Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.] - Involvement and Affiliations:
-
- Senior Research Fellow and Director, Centre for Assessment and Prioritisation, Department of Public Health, University of Otago, Wellington School of Medicine, 2009-present
- Director, Law & Economic Consulting Group (Wellington, New Zealand), 2005-2009
- Medical Consultant, BC Pharmacare (Victoria, Canada), 2001-2002
- Research Director, Western Canada Waiting List Project, University of Alberta (Edmonton, Canada), 1999-2001
- Chief Advisor, Research and Policy Analysis, Health Funding Authority (Wellington, NZ), 1997-1999
- Manager, Special Projects, National Advisory Committee on Health and Disability, Ministry of Health (Wellington, NZ), 1993-1997
- Professional Consultant, RAND Corporation, 1991-1996
- Post-Doctoral Fellow, Health Services Research, RAND Corporation, 1989-1991
- Senior Research Associate, Center for Health Ethics and Policy, University of Colorado, 1988-1993
- Emergency Physician, United Medical Staff of Boulder (Boulder, CO), 1985-1989
- Director, Division of Emergency Medicine, Penn State University, 1982-1984
- Assistant Professor, Medicine and Research, Penn State University, 1982-1984
- Emergency physician, various California hospitals, 1979-1982
- Former North American Medical Director and Medical Consultant, GW Pharmaceuticals
- Education:
-
- PhD, Philosophy, Victoria University, Wellington, 2002
- MA, Philosophy, University of Colorado, 1988
- MD, University of California at San Diego, 1976
- BS, University of California at Irvine, 1972
- Other:
-
- Board Member, Drug Policy Forum Trust, Centre for the Study of Assessment, and New Zealand Drug Policy Forum Trust
- Board of Advisors, Stop the Drug War
- Member, Panel on Cost-effectiveness in Health and Medicine, US Dept. of Health and Human Services, 1993-1996
- Project Director, “Developing a Clinical Practice Guideline for Congestive Heart Failure,” RAND Corporation, 1992-1996
- Residency, Emergency Medicine, Louisville General Hospital, Louisville, KY, 1977-1979
- Internship, Surgery University Hospital, San Diego, CA, 1976-1977
- Quoted in:
